Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_provenance.
- NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_assertion description "[The ability of a high affinity human recombinant antibody (2D03), specific for malondialdehyde-modified apoB-100, to influence formation of atherosclerosis as well as remodelling and neointima formation after a collar-induced injury of the carotid artery was studied in LDL receptor(-/-) mice over-expressing human apoB-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_provenance.
- NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_assertion evidence source_evidence_literature NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_provenance.
- NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_assertion SIO_000772 16677655 NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_provenance.
- NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_assertion wasDerivedFrom befree-20140225 NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_provenance.
- NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_assertion wasGeneratedBy ECO_0000203 NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_provenance.
- befree-20140225 importedOn "2014-02-25" NP203957.RAEFVvviRG0I1pV5Cy_GPG3qdlTt54C6EY20n8speNk8c130_provenance.